Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients
Conditions: Gastric Cancer Interventions: Drug: Lenvatinib and Sintilimab Sponsors: Tianjin Medical University Cancer Institute and Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Hospitals | Research